RxSight RXST Stock
RxSight Price Chart
RxSight RXST Financial and Trading Overview
| RxSight stock price | 4.79 USD |
| Previous Close | 5.33 USD |
| Open | 5.3 USD |
| Bid | 3.87 USD x 100 |
| Ask | 6.46 USD x 200 |
| Day's Range | 5.02 - 5.42 USD |
| 52 Week Range | 5.02 - 16.36 USD |
| Volume | 1.38M USD |
| Avg. Volume | 724.23K USD |
| Market Cap | 216.92M USD |
| Beta (5Y Monthly) | 1.235 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.79 USD |
RXST Valuation Measures
| Enterprise Value | 13.59M USD |
| Trailing P/E | N/A |
| Forward P/E | -9.357142 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.7016264 |
| Price/Book (mrq) | 0.7838444 |
| Enterprise Value/Revenue | 0.107 |
| Enterprise Value/EBITDA | -0.261 |
Trading Information
RxSight Stock Price History
| Beta (5Y Monthly) | 1.235 |
| 52-Week Change | -65.67% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 16.36 USD |
| 52 Week Low | 5.02 USD |
| 50-Day Moving Average | 6.56 USD |
| 200-Day Moving Average | 8.63 USD |
RXST Share Statistics
| Avg. Volume (3 month) | 724.23K USD |
| Avg. Daily Volume (10-Days) | 691.09K USD |
| Shares Outstanding | 41.4M |
| Float | 39.18M |
| Short Ratio | 6.64 |
| % Held by Insiders | 5.65% |
| % Held by Institutions | 93.25% |
| Shares Short | 4.85M |
| Short % of Float | 12.37% |
| Short % of Shares Outstanding | 11.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -36.58% |
| Operating Margin (ttm) | -57.71% |
| Gross Margin | 77.01% |
| EBITDA Margin | -40.80% |
Management Effectiveness
| Return on Assets (ttm) | -11.21% |
| Return on Equity (ttm) | -17.063% |
Income Statement
| Revenue (ttm) | 127.48M USD |
| Revenue Per Share (ttm) | 3.11 USD |
| Quarterly Revenue Growth (yoy) | -18.50% |
| Gross Profit (ttm) | 98.18M USD |
| EBITDA | -52022000 USD |
| Net Income Avi to Common (ttm) | -46638000 USD |
| Diluted EPS (ttm) | -1.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 217.88M USD |
| Total Cash Per Share (mrq) | 5.26 USD |
| Total Debt (mrq) | 10.83M USD |
| Total Debt/Equity (mrq) | 4.05 USD |
| Current Ratio (mrq) | 10.2 |
| Book Value Per Share (mrq) | 6.685 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17570000 USD |
| Levered Free Cash Flow (ttm) | -969250 USD |
Profile of RxSight
| Country | United States |
| State | CA |
| City | Aliso Viejo |
| Address | 100 Columbia |
| ZIP | 92656 |
| Phone | 949 521 7830 |
| Website | https://rxsight.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 461 |
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Q&A For RxSight Stock
What is a current RXST stock price?
RxSight RXST stock price today per share is 4.79 USD.
How to purchase RxSight stock?
You can buy RXST shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RxSight?
The stock symbol or ticker of RxSight is RXST.
Which industry does the RxSight company belong to?
The RxSight industry is Medical Devices.
How many shares does RxSight have in circulation?
The max supply of RxSight shares is 41.4M.
What is RxSight Price to Earnings Ratio (PE Ratio)?
RxSight PE Ratio is now.
What was RxSight earnings per share over the trailing 12 months (TTM)?
RxSight EPS is -1.13 USD over the trailing 12 months.
Which sector does the RxSight company belong to?
The RxSight sector is Healthcare.
RxSight RXST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}